The global clinical trials landscape has transformed significantly over the past five years. The Covid-19 pandemic accelerated the rapid adoption of technology through decentralized clinical trials (DCTs), which allowed for remote data collection, reduced patient travel, and more flexible trial designs.

These changes were necessary to continue clinical research during a time of global uncertainty. As clinical research returns to more traditional models, many contract research organizations (CROs) are moving back to site-centric clinical trials.

However, this return to site-based trials should not mean reverting to outdated practices. The lessons learned from implementing DCTs present a unique opportunity for CROs to optimize efficiencies within site-centric trials. By leveraging digital tools and data-driven insights, CROs can modernize their operations, improve patient experiences, and enhance data accuracy, all while maintaining the rigorous standards required in clinical research.

The advantages of site-centric trials

Site-centric trials offer numerous advantages, particularly in terms of direct oversight, patient safety, and data integrity. The presence of healthcare professionals at trial sites ensures that any adverse events can be quickly identified and addressed. Additionally, site-centric trials facilitate direct interaction between patients and investigators, building trust and ensuring adherence to protocols.

However, traditional site-centric trials often involve cumbersome paper-based data collection methods, which can lead to inefficiencies and errors. These trials also require significant resources in terms of personnel, time, and costs.

Learning from decentralized trials

Decentralized trials introduced a range of digital innovations that can be seamlessly integrated into site-centric models. One of the most significant advances is the use of electronic data capture (EDC) systems, replacing paper-based methods, while also enabling real-time data entry and analysis. Viedoc, a leading provider of EDC systems, has been at the forefront of this shift, offering CROs a comprehensive platform that simplifies data management and enhances trial efficiency.

By incorporating EDC systems into site-centric trials, CROs can significantly reduce the time spent on data entry and validation. This not only speeds up the trial process but also reduces the risk of errors associated with manual data handling. Moreover, EDC systems enable real-time data access, allowing CROs to monitor trial progress and make informed decisions more quickly.

Another key lesson from DCTs is the importance of patient-centric approaches. Remote monitoring and telemedicine were crucial during the pandemic. These innovations can still play a role in site-centric trials. By offering hybrid models that combine in-person visits with remote data collection, CROs can reduce patient burden and increase participation rates. Trials that incorporate patient-centric designs see a 15% higher retention rate compared to traditional models. [1]

Streamlining clinical trial management

Efficient trial management is essential for the success of site-centric clinical trials. Digital tools that automate routine tasks – such as scheduling, reporting, and communication – can free up valuable time for site staff to focus on patient care and protocol adherence. Viedoc’s platform offers features such as automated scheduling, which ensures that visits and assessments are carried out on time, reducing the risk of protocol deviations. The platform receives high ratings for usability so trial staff are not burdened with significant training effort.

Furthermore, data analytics and artificial intelligence (AI) can help CROs identify potential issues before they become critical. Predictive analytics can be used to monitor patient enrolment, adherence, and data quality, allowing CROs to make proactive adjustments. AI-driven tools can also streamline the process of data review and analysis, reducing the time needed to produce trial results.

In addition, adopting cloud-based solutions ensures that all trial data is securely stored and easily accessible to authorized personnel, regardless of their location. This enhances collaboration between site staff, CROs, and sponsors, leading to more efficient trial management.

The future of site-centric trials

As the clinical trial landscape evolves, site-centric trials will remain a vital component of clinical research. However, to stay competitive and meet the demands of increasingly complex protocols, CROs must embrace the digital elements that have emerged from decentralized trials. By integrating these technologies into site-based models and hybrid trials, CROs can optimize efficiencies, improve data quality, and enhance patient experiences.

Viedoc’s solutions provide a clear pathway for CROs looking to modernize their site-centric trials. By combining advanced data capture tools with user-friendly interfaces and robust security features, Viedoc ensures that CROs can conduct high-quality trials without compromising efficiency or accuracy.

Viedoc’s EDC systems offer high usability with a range of features designed to enhance the efficiency, accuracy, and management of clinical trials. These include tools for electronic case report forms (eCRF), randomization, study design, and patient engagement. Download the document below to learn more.

References:

[1] https://www.pharmaceutical-technology.com/sponsored/how-improving-econsent-can-enhance-patient-retention-for-clinical-trials/